Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies. - Wikidata - wikimedia - TriplyDB

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.

http://www.wikidata.org/entity/Q34114798

about

HIV-Host Interactions: Implications for Vaccine Design Harnessing the protective potential of HIV-1 neutralizing antibodies The evolution within us Antibody responses to envelope glycoproteins in HIV-1 infection Virological features associated with the development of broadly neutralizing antibodies to HIV-1 Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains Applying contemporary immunology to elucidate heterologous effects of infant vaccines and to better inform maternal-infant immunization practices.High-Throughput Sequencing-Based Immune Repertoire Study during Infectious Disease HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth Consistency of VDJ Rearrangement and Substitution Parameters Enables Accurate B Cell Receptor Sequence Annotation A Little Help From the Follicles: Understanding the Germinal Center Response to Human Immunodeficiency Virus 1 Infection and Prophylactic Vaccines.Humanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem.HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.Current views on the potential for development of a HIV vaccine.Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller Reversion and T cell escape mutations compensate the fitness loss of a CD8+ T cell escape mutant in their cognate transmitted/founder virus Memory B cells.HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved.Class-switched memory B cells remodel BCRs within secondary germinal centers.Comprehensive antigenic map of a cleaved soluble HIV-1 envelope trimer.Balanced splicing at the Tat-specific HIV-1 3'ss A3 is critical for HIV-1 replication HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies.Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas.Strategies to guide the antibody affinity maturation process Diverse antibody genetic and recognition properties revealed following HIV-1 envelope glycoprotein immunization.Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort Can immunological principles and cross-disciplinary science illuminate the path to vaccines for HIV and other global health challenges?Spatiotemporal hierarchy in antibody recognition against transmitted HIV-1 envelope glycoprotein during natural infection.Dynamics of immunoglobulin sequence diversity in HIV-1 infected individuals.The challenges of modelling antibody repertoire dynamics in HIV infection.Effects of Darwinian Selection and Mutability on Rate of Broadly Neutralizing Antibody Evolution during HIV-1 Infection.Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses.Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike.Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design.

P2860

Q26765966-AC7454CD-36A7-49A4-B6E9-D3B1AE7011AC Q26766153-87FAA54A-86AD-4D85-87E7-C1D1C0E57748 Q26801603-915AB6D0-3095-47B0-B2EB-7621739BA12E Q26991572-A49E747E-4115-4B68-AAF7-4298E267964B Q27025177-C63B58C5-E214-4436-B19C-E3355F5A4A54 Q27319450-A2F23216-C0BC-4B8C-A631-47FA73B9B2EC Q27644415-2A29EA5F-344B-4C04-B247-0F9102118B7C Q27654848-A2E5977A-C081-45B7-9410-A92425AE9CD9 Q27684503-F8D23F33-C596-4488-A6F6-3C7583E8C226 Q27687122-5D1284E3-316E-4EEB-848A-15821878F7A5 Q28068214-94260AE1-916A-4828-A890-1A9913BF7774 Q28086826-BC81A87A-E0ED-45C3-B38A-6FDCDF32C33B Q28602773-AACD9745-2171-4B08-97AD-83F1898ADC65 Q30234577-7D7F382D-91CE-43C8-A5AE-C24613C14432 Q30234773-46B088AF-724C-49FB-BCD0-4016A9C17D9C Q30393763-A4BA6A76-CD66-4DC0-B235-624C00B3B603 Q30397595-A15A46B9-2C12-4D87-814E-4490EA64C402 Q33620546-5CD4C39F-D95D-4575-ACAC-F78C930F9A1A Q33786447-39ECFC93-FA4F-46DE-901B-FC5F1AEF9086 Q33910862-66D9AC2A-61A5-42C6-950B-1C39F1AE2C3B Q34462470-DB1DECB4-B057-4D5B-9104-85322D9DB1F0 Q34527469-C53B3012-BB78-4B18-AA93-7C712DE25DC5 Q34991017-4A2B992E-5534-4863-957C-9FFA58E73E19 Q35073270-230150A6-B92E-4ED1-B065-E21C43AA1DD9 Q35097102-13A61142-7F05-4701-B7EC-BE4B5EB83AB8 Q35217426-84CDB879-83DF-4AB3-A195-9C253B2DEB33 Q35575811-C53DD886-0C7A-4C7D-AB3C-748284741279 Q35640998-4734EF4A-F2B5-462B-A31A-524B0D5BB66A Q35677620-20FB7119-D8E6-4EFE-B01E-5CE019985086 Q35685300-6397DF77-2279-4B16-BE56-154F46A3CBEC Q35691113-17B49224-BA6D-4A2E-8E62-9AA9E6D74FFB Q35894094-086FF465-AA12-4C19-9856-551915BB7592 Q35923859-C7810224-FFF0-4841-8D9C-29E55BE19218 Q35925331-F9A7C2F0-7FDA-4D88-86D6-2FB003C3A869 Q35926722-62D3AA58-98EB-48F5-A941-1C40EF82AAB0 Q35926734-9EB57796-A4D3-4D17-878C-E8EF189E96E8 Q36020766-B5AB2817-8311-440F-A55A-87ECFB1AEF61 Q36053810-FEE734DF-E3E2-4271-AA48-C2096716688B Q36100426-0ABFF9C6-FE69-4881-B2A6-AEA565EC0D2C Q36112751-9D651651-54DB-498E-91B2-5BE13F7AED98

P2860

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.

http://www.wikidata.org/entity/Q34114798

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.

@ast

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.

@en

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.

@nl

type

label

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.

@ast

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.

@en

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.

@nl

prefLabel

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.

@ast

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.

@en

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.

@nl

P1433

Q34114798-A351D88B-460B-44A8-A50C-0851EF782C00

P1476

Q34114798-EC4F730A-756A-423F-B164-ED17EEA5E437

P2093

Q34114798-02DD2264-C187-4A86-A7D9-0BF97B0D5DF7

Q34114798-225710BC-3655-4BDE-BEF0-15773A3C43CC

Q34114798-2F6BA14C-C4F5-458D-98EE-14083B683616

Q34114798-44DA8F2C-1B65-4A61-8A20-0590C37E3B80

Q34114798-4A160876-8FDD-4226-9190-A6FD545EF6FE

Q34114798-4B6E072F-F326-433F-B917-0F85051BF9D9

Q34114798-508C1E2F-5240-433C-B790-539C859928CE

Q34114798-67B3767F-6EDD-428D-BB5C-95D5D2E4378E

Q34114798-6D8202AE-B7FA-4C80-8EAC-25373EB0B0CC

Q34114798-8DB72F7C-A8F0-47DA-99D7-3DBD3F35264C

P2860

Q34114798-00EC40A4-24A9-40C9-9E26-0EF556E02004

Q34114798-0410FF23-0E8E-41E5-9AD7-24C8C45EC001

Q34114798-0A0E3B29-F841-47A5-A99A-4F9A0035FB16

Q34114798-0ADDD692-670C-483D-855A-B21105C7C818

Q34114798-0D3999B3-DE51-41F9-8AD2-8F2C40FA61B1

Q34114798-12D40E82-3203-4408-B7E8-A5A4608684DA

Q34114798-27C6E0DA-2B51-4852-A232-651576590B0B

Q34114798-2D1962DD-D8AF-44F0-9E41-38F2342D74B6

Q34114798-337E9A23-E606-4EAF-ACE9-2A5A8B665185

Q34114798-34EB2828-7D4E-46B8-AC6C-B7B80A77D87F

P304

Q34114798-3DF9DD3C-1BE8-4C13-9CDF-0CBBF661939F

P31

Q34114798-4CE179BD-1ABD-4D25-8FC1-F8A987DDED4F

P356

Q34114798-0B344E67-39DA-41D2-9CD4-D9ED62D8FF2F

P407

Q34114798-EB8F5181-AB20-48FB-8419-6A5C4C6D3246

P433

Q34114798-E968666D-E835-4636-8404-FC40A29CC3A8

P478

Q34114798-F9AB965F-234C-447F-9506-1B77A37E733E

P50

Q34114798-05027C09-969C-48A5-ADF5-24E65882F046

Q34114798-1BA08C62-7A7F-470B-A36D-F1F84F22F9A9

Q34114798-3605A03E-B309-4936-8179-6C921E453F23

Q34114798-3A89356C-B32F-45CC-871C-AF55501C3A13

Q34114798-8A56ED6A-5840-4B76-996B-C4CA5FA137B8

Q34114798-99A53BED-1C50-4D45-9B70-40AAD802A891

Q34114798-B29DD289-8DF3-475B-89FB-9A32CD3AD84F

Q34114798-BFF83288-321E-4F1B-A6DE-849DA072D522

Q34114798-C17CC489-12C0-4CD4-A291-1B38B8E0ACEB

Q34114798-DB54FFF4-4E2F-453A-8F1B-DA317ECF766C

P577

Q34114798-6399B337-47A8-43E4-8794-884C3F0DEBFC

P5875

Q34114798-3A3191A1-5FD9-44F2-9261-BABE2BB26043

P698

Q34114798-1A1B853B-2929-4580-BA65-73C03D3E688A

P921

Q34114798-B6BA5D17-E825-4E85-BE52-DEC3EFE27331

P932

Q34114798-5F7568E5-38F5-4354-B190-231BA14B2609

P356

J.CELL.2014.06.022

P1433

P1476

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.

@en

P2093

Amit Kumar

http://www.w3.org/2001/XMLSchema#string

Fangping Cai

http://www.w3.org/2001/XMLSchema#string

Feng Gao

http://www.w3.org/2001/XMLSchema#string

Gift Kamanga

http://www.w3.org/2001/XMLSchema#string

Hongshuo Song

http://www.w3.org/2001/XMLSchema#string

Hua-Xin Liao

http://www.w3.org/2001/XMLSchema#string

Kwan-Ki Hwang

http://www.w3.org/2001/XMLSchema#string

M Anthony Moody

http://www.w3.org/2001/XMLSchema#string

Mark Berrong

http://www.w3.org/2001/XMLSchema#string

Mattia Bonsignori

http://www.w3.org/2001/XMLSchema#string

P2860

Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals

HIV-1 neutralizing antibodies: understanding nature's pathways

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies

Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer

Overview of the CCP4 suite and current developments

Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

P304

481-491

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELL.2014.06.022

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

158

http://www.w3.org/2001/XMLSchema#string

P50

Peter T. Hraber

Beatrice H. Hahn

David C Montefiori

P577

2014-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264292140

http://www.w3.org/2001/XMLSchema#string

P698

25065977

http://www.w3.org/2001/XMLSchema#string

P921

P932

4150607

http://www.w3.org/2001/XMLSchema#string